Immunosuppression is a risk factor for worse survival and disease‐specific death in cutaneous squamous cell carcinoma

• Main Authors: Adina Greene (Author), Angelina S. Hwang (Author), Jacob A. Kechter (Author), Blake W. Boudreaux (Author), Puneet Bhullar (Author), Kevin J. Severson (Author), Richard J. Butterfield (Author), Nan Zhang (Author), Leila M. Tolaymat (Author), Catherine A. Degesys (Author), Shari A. Ochoa (Author), Christopher J. Arpey (Author), Christian L. Baum (Author), Aaron R. Mangold (Author)
• Format: Book
• Published: Wiley, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Previous literature on cutaneous squamous cell carcinoma (cSCC) suggests that the incidence, rate of metastasis, and tumour severity of cSCC are higher in immunosuppressed patients than in immunocompetent patients. However, current literature lacks an extensive comparison of cSCC...